InterAx is developing a technology platform for discovery of novel GPCR-targeting medicines
InterAx Biotech helps pharmaceutical companies to develop new and better drugs. Their unique combination of computational methods and innovative biological products allows for fast and comprehensive characterization of potential new drugs. Costly clinical trials can then be performed with reduced risks.
Videos und Präsentationen
Startup Champions: venture leaders USA 2016 kick-off event (April 21st, 2016, EPFL)
|Dieses Profil mit anderen teilen|